Digital PrEP Micro-Intervention for PWUD in Kazakhstan

ConditionsDrug UseHIV
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University

About this trial

This study is a mixed-methods pilot designed to evaluate the feasibility, acceptability, and appropriateness of a brief digital micro-intervention aimed at reducing stigma-related barriers to pre-exposure prophylaxis (PrEP) engagement among people who use drugs (PWUD) in Kazakhstan. Participants will complete baseline and post-intervention surveys and receive structured informational content via Telegram or WhatsApp over approximately 2-3 weeks. The intervention focuses on addressing anticipated stigma, confidentiality concerns, and misinformation that may prevent PWUD from seeking PrEP services. No clinical procedures, medication provision, or biological specimen collection are involved.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Self-reported drug use within the past six months

HIV-negative or unknown HIV status (self-reported)

Not currently taking PrEP

Able to provide informed consent

Disqualifiers

Are unable to provide informed consent

Do not have access to a mobile device for digital message delivery

Are currently enrolled in another PrEP behavioral intervention study

Trial design

Design model

Single group

Treatments tested in this trial

  • Dgital micro-intervention

    Behavioral

    Intervention will include 6-10 brief modules delivered asynchronously consisting of text-based content with optional simple visuals. There is no requirement for participant response. Messages will avoid explicit labeling referencing HIV or drug use in preview text and be written using neutral language. Participants are allowed to discontinue receipt at any time.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Digital micro-interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mean Score Acceptability of Intervention Measure (AIM)

Acceptability of the intervention will be assessed using the Acceptability of Intervention Measure (AIM). It has 4-items scored on a 5-point Likert scale summed to achieve a total score. Total score range of 0-20. Higher scores indicate more acceptability.

Time frame
Baseline and Post intervention (Week 4)
2

Mean Score Intervention Appropriateness Measure (IAM)

The Intervention Appropriateness Measure (IAM) is a 4-item, 5-point Likert scale ( 1=Completely Disagree to 5=Completely Agree) used to evaluate the perceived fit, relevance, or compatibility of an intervention or implementation strategy. Total score range 0-20. Higher scores indicate better appropriateness.

Time frame
Baseline and Post intervention (Week 4)
3

Mean Score Feasibility of Intervention Measure (FIM)

Feasibility of intervention measured using Feasibility of Intervention Measure (FIM)- a 4-item instrument to assess perceived intervention feasibility. Total score 1-5 with higher scores indicating greater feasibility.

Time frame
Baseline and Post intervention (Week 4)

Secondary outcomes

1

Change in PrEP knowledge

Measured by a structured survey. Total score range 1-10. Higher scores indicate increased knowledge.

Time frame
Baseline and Post intervention (Week 4)
2

Change in perceived stigma-related barriers

Measured by a structured survey. Total score range 8-40. Higher scores indicate more barriers.

Time frame
Baseline and Post intervention (Week 4)
3

Change in readiness to seek PrEP

Measured by Likert scale survey items. Total score range 1-5. Higher scores indicate increased readiness.

Time frame
Baseline and Post intervention (Week 4)
4

Mean number of clicks or links accessed

Mean number of clicks or links accessed among participants that used the intervention

Time frame
Baseline and Post intervention (Week 4)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yale University

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: